This table presents recent patent oppositions filed by Alkermes Pharma Ireland Limited against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3866765Injectable Long-Acting Naltrexone Microparticle CompositionsCHONG KUN DANG PHARMACEUTICAL CORP.Nov 6, 2024
EP3566696Risperidone Sustained Release Microsphere CompositionGENEORA PHARMA (SHIJIAZHUANG) CO., LTD.Jul 7, 2021
EP3104844Complexes Of Sirolimus And Its Derivatives, Process For The Preparation Thereof And Pharmaceutical Compositions Containing ThemDRUGGABILITY TECHNOLOGIES IP HOLDCO LIMITEDNov 11, 2020
EP3199146Risperidone Sustained Release Microsphere CompositionNANJING LUYE PHARMACEUTICAL CO., LTD.Apr 17, 2020
EP2582697Nanostructured Aprepitant Compositions, Process For The Preparation Thereof And Pharmaceutical Compositions Containing ThemDRUGGABILITY TECHNOLOGIES IP HOLDCO (JERSEY) LIMITEDJun 27, 2018
EP3010962Preparation Of Polylactide-Polyglycolide Microparticles Having A Sigmoidal Release ProfilePHARMATHEN S.A.Apr 26, 2018

The following table provides an overview of the latest patents of Alkermes Pharma Ireland Limited that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2445502Sep 28, 2022Heterocyclic Compounds For The Treatment Of Neurological And Psychological Disorders1
EP3182958May 18, 2022Aripiprazole Prodrug Compositions1
EP3253377May 12, 2021Monomethylfumarate Prodrug Compositions4
EP2970101Jun 6, 2018Prodrugs Of Fumarates And Their Use In Treating Various Deseases3